Mymetics Corp (MYMX): PCI Biotech, preclinical research collab...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Wednesday, 09/06/2023 2:57:03 AM

Wednesday, September 06, 2023 2:57:03 AM

PCI Biotech, preclinical research collaborator, performs write down of share capital.

September 1, 2023.

https://finance.yahoo.com/news/pci-biotech-write-down-share-090400583.html

https://www.accesswire.com/viewarticle.aspx?id=713978

Keep Last Read

Next 10 Prev Next

Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM

InvestorsHub NewsWire

Only $200 per official company press release!